Mutation Status and Immunoglobulin Gene Rearrangements in Patients from Northwest and Central Region of Spain with Chronic Lymphocytic Leukemia
Figure 2
Kaplan-Meier survival curve comparing OS and TTFT between patients with M-CLL (125 cases) and U-CLL (99 cases). (a) Median OS for U-CLL: 117 months; median OS for M-CLL 215 months. The difference is significant at the level (log-rank test). (b) Median TTFT for U-CLL: 29 months; median TTFT for M-CLL: 227 months. The difference is significant at the level (log-rank test).
